
Alprazolam
Alprazolam is a fast-acting benzodiazepine for short-term treatment of generalized anxiety disorder and for panic disorder. Short trials show it works better than placebo, with relief of panic within the first one or two weeks. The boxed warning covers opioids, abuse and addiction, and dependence with dangerous withdrawal; alcohol, kava and cannabis can add to its sedation, and valerian is best treated the same way although its evidence is weaker.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Adults with generalized anxiety disorder needing short-term relief, or with panic disorder, treated by a prescriber
Common dosing range
Set by a prescriber. For GAD the label starts at 0.25 to 0.5 mg three times daily, up to a maximum of 4 mg per day; for panic disorder it starts at 0.5 mg three times daily (Xanax XR 0.5 to 1 mg once daily, usual range 3 to 6 mg). Older adults and people with liver impairment start at 0.25 mg two or three times daily
When to expect effects
Blood levels peak in 1 to 2 hours; in a large panic disorder trial, improvement appeared by weeks 1 and 2
Watch out for
Boxed warnings: profound sedation, slowed breathing, coma and death with opioids; abuse, misuse and addiction, which can lead to overdose or death; and physical dependence, with withdrawal reactions that can be life-threatening after abrupt stopping or rapid dose reduction. Alcohol and other sedatives add to its effects, and strong CYP3A blockers such as ketoconazole and itraconazole are contraindicated.
What is it
Alprazolam is a prescription benzodiazepine and a Schedule IV controlled substance, sold as Xanax, Xanax XR and generic tablets. The FDA label approves immediate-release Xanax for the acute treatment of generalized anxiety disorder (GAD) in adults and for panic disorder with or without agoraphobia in adults; Xanax XR, taken once daily, is approved for panic disorder. Alprazolam carries the boxed warning shared by all benzodiazepines: combining it with opioids may cause profound sedation, slowed breathing, coma and death; it carries risks of abuse, misuse and addiction; and continued use can lead to physical dependence, with withdrawal reactions that can be life-threatening if it is stopped suddenly. Because it is a sedative, other sedating products, including alcohol, kava, valerian and cannabis, are the main supplement and drink concerns.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
panic disorder (short-term treatment) Good Evidence | Better than placebo on most measures at 8 weeks, with faster onset than imipramine | Adults with panic disorder who need relief quickly | Improvement by weeks 1 to 2 |
panic disorder (pooled trials) Limited Evidence | Moderate in short trials; risk ratio 1.65 for response vs placebo | Adults with panic disorder in short-term treatment | Short-term trials of weeks |
generalized anxiety disorder (short-term) Limited Evidence | Small to moderate; 2.5 points more improvement on the Hamilton anxiety scale than placebo | Adults with generalized anxiety disorder needing short-term relief | Psychic anxiety improved by week 1 |
panic disorder (short-term treatment)
- Effect
- Better than placebo on most measures at 8 weeks, with faster onset than imipramine
- Best fit
- Adults with panic disorder who need relief quickly
- Time
- Improvement by weeks 1 to 2
panic disorder (pooled trials)
- Effect
- Moderate in short trials; risk ratio 1.65 for response vs placebo
- Best fit
- Adults with panic disorder in short-term treatment
- Time
- Short-term trials of weeks
generalized anxiety disorder (short-term)
- Effect
- Small to moderate; 2.5 points more improvement on the Hamilton anxiety scale than placebo
- Best fit
- Adults with generalized anxiety disorder needing short-term relief
- Time
- Psychic anxiety improved by week 1
Evidence for 3 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
panic disorder (short-term treatment)
Disease adjunctThe Cross-National Collaborative Panic Study (Phase Two) randomized 1,168 people with panic disorder at 12 centers to alprazolam, the antidepressant imipramine or placebo for 8 weeks. Improvement appeared with alprazolam by weeks 1 and 2 and with imipramine by week 4. By week 8 the two drugs had similar effects, and both were better than placebo on most outcome measures. The trial did not test long-term use, dependence or what happens after stopping.
Bottom line: In a large 8-week trial, alprazolam relieved panic disorder sooner than imipramine and both beat placebo.
panic disorder (pooled trials)
Disease adjunctA 2019 Cochrane review of 24 trials with 4,233 participants found benzodiazepines more likely than placebo to bring a treatment response (risk ratio 1.65; about 4 people treated for one extra response) and remission, with fewer dropouts overall but more dropouts due to side effects (risk ratio 1.58). The evidence was low quality, and the trials were short and did not examine dependence or withdrawal. A 2023 Cochrane network meta-analysis of 70 trials ranked alprazolam among the most effective medicines for response and for reducing the number of panic attacks, again with low-quality evidence for benzodiazepines.
Bottom line: Pooled short trials suggest benzodiazepines, including alprazolam, help panic disorder, but the evidence is low quality.
Evidence is mixed
The reviewers note that guidelines recommend SSRI antidepressants first for panic disorder because of benzodiazepine dependence and withdrawal, which the pooled trials did not measure.
generalized anxiety disorder (short-term)
Disease adjunctIn a 4-week randomized trial in outpatients with generalized anxiety disorder (Hamilton anxiety score 20 or higher), alprazolam reduced the Hamilton anxiety score by 10.9 points versus 8.4 with placebo. It improved psychic anxiety symptoms from week 1 but not somatic (physical) anxiety symptoms. A 2019 network meta-analysis of 89 trials with 25,441 patients found benzodiazepines effective for generalized anxiety disorder but poorly tolerated compared with placebo.
Bottom line: Alprazolam eases generalized anxiety in the short term, but side effects make it less well tolerated than several alternatives.
How it works
How to take it
What to track
Bottom line: A prescriber sets the dose and any taper; keep alcohol and sedating herbs out of the picture unless your prescriber agrees.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Boxed warning: using benzodiazepines with opioids may result in profound sedation, respiratory depression, coma and death. The label reserves the combination for people whose other options are inadequate, at the lowest doses for the shortest time.
Boxed warning: abuse, misuse and addiction, which can lead to overdose or death. Abuse and misuse commonly involve other medicines, alcohol or illicit substances, which raises the risk of serious outcomes.
Boxed warning: dependence and withdrawal reactions. Continued use may lead to clinically significant physical dependence, with risk rising with longer use and higher doses; abrupt stopping or rapid dose reduction may cause acute withdrawal reactions, including seizures, that can be life-threatening, and some people develop protracted withdrawal lasting weeks to more than 12 months.
Impaired driving and machine operation; worsening depression and suicidal thinking in people with depression; episodes of mania or hypomania; deaths in people with severe lung disease shortly after starting; and sedation or withdrawal in newborns after use late in pregnancy
Who should avoid it
- People allergic to alprazolam or other benzodiazepines (angioedema has been reported), and people taking strong CYP3A inhibitors such as ketoconazole or itraconazole, except ritonavir (contraindicated)
- People with severe lung disease or impaired breathing need close monitoring; the label reports deaths shortly after starting alprazolam in people with severe pulmonary disease
- People with a history of substance use disorder, or with depression, need careful assessment and monitoring by the prescriber
Pregnancy & breastfeeding
Pregnancy: the label says newborns of mothers who used benzodiazepines late in pregnancy have had sedation (breathing problems, sluggishness, low muscle tone) and withdrawal symptoms, and that published observational studies do not report a clear link between benzodiazepines and major birth defects. Newborns exposed during pregnancy or labor should be watched for sedation, breathing problems, low muscle tone, feeding problems and withdrawal. A pregnancy registry for psychiatric medicines collects outcomes. Breastfeeding: alprazolam has been found in breast milk, and there are reports of sedation, poor feeding and poor weight gain in infants exposed to benzodiazepines through milk. Because of the risk of sedation and withdrawal in the infant, the label advises that breastfeeding is not recommended during treatment.
Interactions
The Xanax label says alprazolam adds to the effects of other central nervous system depressants, including ethanol, and its Medication Guide warns that taking benzodiazepines with alcohol can cause severe drowsiness, breathing problems, coma and death. Do not drink while taking alprazolam unless your prescriber has told you otherwise, and call emergency services for anyone who is hard to wake or breathing slowly.
Boxed warning: benzodiazepines with opioids may cause profound sedation, respiratory depression, coma and death. In a study of US veterans on opioid pain medicines, a current benzodiazepine prescription was linked to 3.86 times the risk of overdose death. The label limits the combination to people whose other options are inadequate, at the lowest doses for the shortest time.
Strong CYP3A blockers are contraindicated with alprazolam, except ritonavir, which needs a dose adjustment; ketoconazole and itraconazole raised alprazolam levels 3.98-fold and 2.70-fold. The label says to avoid moderate or weak blockers or consider a lower alprazolam dose. Tell every prescriber and pharmacist that you take alprazolam.
Kavain, a main kava compound, strengthens GABA-A receptors, the same calming system alprazolam acts on, and a systematic review of herb-drug interactions reports a semicomatose state when kava was taken with alprazolam. Kava has also caused liver injury in some people. Avoid combining them, and talk to your prescriber before using any calming herbal product; the label warns that stopping alprazolam suddenly can cause dangerous withdrawal, so any change goes through your prescriber.
Cannabis can cause sedation and poor coordination, and the Xanax label says alprazolam adds to the effects of other drugs that depress the brain. The label for dronabinol, a prescription form of THC, also lists benzodiazepines among drugs that can add to its sedation and its effect on driving. Direct evidence for THC with alprazolam is limited: in a small lab study in 10 cannabis users, diazepam changed the effects of oral THC very little, while a 2024 systematic review found that CBD raised levels of the active form of clobazam, another benzodiazepine, and caused more sedation. Do not drive after using both, and tell your prescriber about any cannabis use.
Valerenic acid from valerian enhances GABA-A receptors, and a case report described tremor, dizziness and muscle fatigue in a man taking lorazepam with valerian and passionflower. In 12 healthy volunteers, 14 nights of valerian raised the peak level of alprazolam from 25 to 31 ng/ml without changing overall exposure, and a review found no clinically relevant valerian interactions. Treat valerian as a second sedative and use it only if your prescriber agrees.
Both promote sleepiness, so together they may add to drowsiness and slower reactions, especially in older adults. In a randomized trial of 80 adults before surgery, a single dose of alprazolam plus melatonin relieved anxiety better than either alone without worsening sedation scores or memory effects, but nightly use together has not been studied. Tell your prescriber if you use melatonin and avoid driving until you know how the combination affects you.
St. John's wort speeds up CYP3A4, the enzyme that clears alprazolam. In 12 healthy volunteers, 14 days of a standard extract halved alprazolam exposure, which could weaken its effect, while a low-hyperforin extract made little difference. Tell your prescriber before starting or stopping the herb, since levels can rise again after stopping, and do not change your alprazolam dose on your own.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.
Warnings (4)
+ alcohol
criticalAlcohol and alprazolam (Xanax) both depress the central nervous system by enhancing GABA-A receptor activity. Taken together they produce additive, and sometimes synergistic, sedation, slowed breathing, and impaired coordination, which substantially raises the risk of overdose and death even when neither is taken in a large amount.
+ kava
highKava's active compounds (kavalactones) act on the brain's GABA-A receptor, the same inhibitory system that alprazolam, a benzodiazepine, enhances. Taken together they cause additive central nervous system depression. A published case report describes a man who became semi-comatose after combining kava with alprazolam. Kava also carries an independently documented risk of liver injury.
+ melatonin
moderateAlprazolam and melatonin both promote sleep and can produce additive sedation, so taking them together may increase drowsiness, slow reaction time, and carry over into next-day grogginess. The combination is generally manageable but warrants your prescriber's awareness, especially for older adults and anyone who drives in the morning.
+ st. john's wort
moderateSt. John's wort speeds up CYP3A4, the liver enzyme that clears alprazolam (Xanax), which can lower alprazolam levels and weaken its effect. In 12 healthy volunteers, 14 days of St. John's wort halved alprazolam exposure and cut its half-life from about 12 to 6 hours. The effect depends on the product: a low-hyperforin extract tested in 28 volunteers, and a smaller study in 7 volunteers, showed no meaningful change. The Xanax label advises caution with CYP3A inducers but does not name St. John's wort, and no study measured anxiety control in patients.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I take kava or valerian with alprazolam?⌄
Not without your prescriber. Both herbs act on the same GABA-A calming system, and kava with alprazolam has been linked to a semicomatose state. Valerian's interaction evidence is weaker, but it is still best treated as a second sedative.
Can I take melatonin with Xanax?⌄
Tell your prescriber first. Both cause sleepiness. In a trial of single doses before surgery, adding melatonin to alprazolam did not worsen sedation, but regular nightly use together has not been studied.
Can I drink alcohol on alprazolam?⌄
No. The label says alprazolam adds to the effects of alcohol, and its Medication Guide warns the combination can cause severe drowsiness, breathing problems, coma and death.
Is it safe to use cannabis while taking alprazolam?⌄
It is best avoided. Both can cause sedation and poor coordination, so do not drive after using both. Direct studies of THC with alprazolam are limited; tell your prescriber about any cannabis or CBD use.
Why can't I just stop taking alprazolam?⌄
The boxed warning says abrupt stopping or a rapid dose reduction after continued use can cause withdrawal reactions, including seizures, that can be life-threatening. Your prescriber can plan a gradual taper if a change is needed.
References by claim
panic disorder (short-term treatment)
PMID 1540759 · PubMed (1992) link
panic disorder (pooled trials)
generalized anxiety disorder (short-term)
Safety
Xanax (alprazolam) prescribing information and Medication Guide · DailyMed (FDA label) link
Interaction: Kava (Piper methysticum)
Interaction: Cannabis and THC products
Interaction: Valerian (including valerian tea)
Interaction: Melatonin
Pokharel et al., 2014 · PMC (2014) link
Interaction: Opioids (oxycodone, hydrocodone, tramadol, codeine, morphine, fentanyl, methadone, buprenorphine)
Park et al., 2015 · PMC (2015) link
Track Alprazolam with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
